The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Etiology, Management, and Outcome of the Budd-Chiari Syndrome
Open accessAbstract
BACKGROUND: The Budd-Chiari syndrome (BCS) is hepatic venous outflow obstruction. What is known about the syndrome is based on small studies of prevalent cases. OBJECTIVE: To characterize the causes and treatment of incident BCS. DESIGN: Consecutive case series of patients with incident BCS, enrolled from October 2003 to October 2005 and followed until May 2006. SETTING: Academic and nonacademic hospitals in France, Spain, Italy, Great Britain, Germany, Belgium, the Netherlands, Portugal, and Switzerland. PATIENTS: Persons older than 16 years with definite hepatic outflow obstruction diagnosed by imaging. Persons with hepatic outflow obstruction due to heart failure, sinusoidal obstruction syndrome, cancer, or liver transplantation were excluded. MEASUREMENTS: Signs and symptoms; laboratory and imaging findings; diagnosis; treatment; and overall, transplantation-free, and intervention-free survival. RESULTS: 163 incident cases of BCS were identified. Median follow-up was 17 months (range, 0.1 to 31 months). Most patients (84%) had at least 1 thrombotic risk factor, and many (46%) had more than 1; the most common was myeloproliferative disorders (49% of 103 tested patients). Patients were mainly treated with anticoagulation (140 patients [86%]), transjugular intrahepatic portosystemic shunting (56 patients [34%]), or liver transplantation (20 patients [12%]), and 80 patients (49%) were managed noninvasively. Only 3 patients underwent surgical shunting. The survival rate was 87% (95% CI, 82% to 93%) at 1 year and 82% (CI, 75% to 88%) at 2 years. LIMITATION: Treatment was not standardized across all centers, and data on important clinical variables were missing for some patients. CONCLUSION: Most patients with BCS have at least 1 thrombotic risk factor, and many have more than 1; myeloproliferative disorders are most common. One- and 2-year survival rates are good with contemporary management, which includes noninvasive therapies (anticoagulation and diuretics) and invasive techniques. Transjugular intrahepatic portosystemic shunting seems to have replaced surgical shunting as the most common invasive therapeutic procedure. PRIMARY FUNDING SOURCE: Fifth Framework Programme of the European Commission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
Self-citationKoster, T., Vandenbroucke, J., Rosendaal, F., de Ronde, H., Briët, E., & Bertina, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,239
Self-citationWorld distribution of factor V Leiden
Rees, D. C., Cox, M., & Clegg, J. B. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91803-5 · Cited by 1,156
Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., & Miletich, J. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321403 · Cited by 1,035
Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
Denninger, M.-H., Chaït, Y., Casadevall, N., Hillaire, S., Guillin, M.-C., Bezeaud, A., Erlinger, S., Briere, J., & Valla, D. (2000) · Hepatology · doi:10.1002/hep.510310307 · Cited by 686
Self-citationBudd–Chiari syndrome: a review by an expert panel
Janssen, H. L. A., Garcia-Pagan, J.-C., Elias, E., Mentha, G., Hadengue, A., & Valla, D.-C. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00434-8 · Cited by 491
Self-citationJanssen, H. L. A., Meinardi, J. R., Vleggaar, F. P., Uum, S. H. M. V., Haagsma, E. B., van der Meer, F. J. M., van Hattum, J., Chamuleau, R. A. F. M., Adang, R. P. R., Vandenbroucke, J. P., et al. (2000) · PubMed · doi:10.1182/blood.v96.7.2364 · Cited by 380
Self-citationMurad, S. D., Valla, D.-C., de Groen, P. C., Zeitoun, G., Hopmans, J. A. M., Haagsma, E. B., van Hoek, B., Hansen, B. E., Rosendaal, F. R., & Janssen, H. L. A. (2004) · Hepatology · doi:10.1002/hep.20064 · Cited by 357
Self-citationPrimary Myeloproliferative Disorder and Hepatic Vein Thrombosis
Valla, D. C., Casadevall, N., Lacombe, C., Varet, B. R., GOLDWASSER, E., FRANCO, D., MAILLARD, J.-N., PARIENTE, E. A., Leporrier, M., RUEFF, B., et al. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-3-329 · Cited by 299
Self-citationAiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome
Plessier, A., Sibert, A., Consigny, Y., Hakimé, A., Zappa, M., Denninger, M., Condat, B., Farges, O., Chagneau, C., de Lédinghen, V., et al. (2006) · Hepatology · doi:10.1002/hep.21354 · Cited by 292
Self-citation
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
EASL Clinical Practice Guidelines: Vascular diseases of the liver
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.040 · Cited by 808
Northup, P. G., Garcia‐Pagan, J. C., Garcia‐Tsao, G., Intagliata, N. M., Superina, R. A., Roberts, L. N., Lisman, T., & Valla, D. C. (2021) · Hepatology · doi:10.1002/hep.31646 · Cited by 667
Self-citationMyeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis
Smalberg, J. H., Arends, L. R., Valla, D. C., Kiladjian, J.-J., Janssen, H. L. A., & Leebeek, F. W. G. (2012) · Blood · doi:10.1182/blood-2011-09-376517 · Cited by 377
Self-citation
Metadata
- Authors
- Murad, S. D., Plessier, A., Hernandez-Guerra, M., Fabris, F., Eapen, C. E., Bahr, M. J., Trebicka, J., Morard, I., Lasser, L., Heller, J., Hadengue, A., Langlet, P., Miranda, H., Primignani, M., Elias, E., Leebeek, F. W., Rosendaal, F. R., Garcia-Pagan, J.-C., Valla, D. C., Janssen, H. L. A., & for EN-Vie (European Network for Vascular Disorders of the Liver)*
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2009-08-04
- Volume
- 151
- Issue
- 3
- Pages
- 167-175
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2153802696
- Cited by
- 532
- References
- 22
- FWCI
- 16.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Etiology, Management, and Outcome of the Budd-Chiari Syndrome. https://app.cochat.ai/papers/10.7326/0003-4819-151-3-200908040-00004
- The paper
- Murad, S. D., Plessier, A., Hernandez-Guerra, M., Fabris, F., Eapen, C. E., Bahr, M. J., Trebicka, J., Morard, I., Lasser, L., Heller, J., Hadengue, A., Langlet, P., Miranda, H., Primignani, M., Elias, E., Leebeek, F. W., Rosendaal, F. R., Garcia-Pagan, J.-C., Valla, D. C., . . . for EN-Vie (European Network for Vascular Disorders of the Liver)*. (2009). Etiology, Management, and Outcome of the Budd-Chiari Syndrome. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-151-3-200908040-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.